Symplicity^(TM)器械特征及临床研究进展  

Characteristics and Research Progress of Symplicity^(TM) System

作　　者：李浪[1] 黄江南[1] 

机构地区：[1]广西医科大学第一附属医院心血管内科,广西南宁530021

出　　处：《中国医疗设备》2014年第5期5-7,共3页China Medical Devices

摘　　要：去肾神经术治疗高血压已经被多项临床实验证实了其安全性和有效性,SymplicityTM是第一个进行临床试验,并通过欧盟CE认证进行临床治疗的射频导管消融肾去交感化治疗系统,它包括单极和多极消融导管系列。近期关于SymplicityTM导管相关的临床试验证实,消融后血压可明显降低,且并发症发生率维持在较低水平。更多的临床试验正在进行中,本文就SymplicityTM的特征及临床研究进展作一阐述。Catheter-based renal denervation（RDN） has become a novel technique for the treatment of resistant hypertension. SymplicityTM System is the fi rst application applied to clinical trials for the treatment of hypertension. The system has passed the EU＇s CE certifi cation. The safety and effi cacy of the system have been proved in many clinical trials. More clinical trials and long-term follow-up are ongoing. This review will focus on the characteristics and relevant clinical trials of the radiofrequency ablation catheter system.

关 键 词：顽固性高血压 去肾交感神经术 射频消融导管系统 

分 类 号：R197.39[医药卫生—卫生事业管理] R544.1[医药卫生—公共卫生与预防医学]